| Literature DB >> 29344414 |
Ningqun Wang1, Shaozhen Ji2, Hao Zhang3, Shanshan Mei2, Lumin Qiao4, Xianglan Jin5.
Abstract
The Cistanche species ("Rou Cong Rong" in Chinese) is an endangered wild species growing in arid or semi-arid areas. The dried fleshy stem of Cistanches has been used as a tonic in China for many years. Modern pharmacological studies have since demonstrated that Herba Cistanches possesses broad medicinal functions, especially for use in anti-senescence, anti-oxidation, neuroprotection, anti-inflammation, hepatoprotection, immunomodulation, anti-neoplastic, anti-osteoporosis and the promotion of bone formation. This review summarizes the up-to-date and comprehensive information on Herba Cistanches covering the aspects of the botany, traditional uses, phytochemistry and pharmacology, to lay ground for fully elucidating the potential mechanisms of Herba Cistanches' anti-aging effect and promote its clinical application as an anti-aging herbal medicine.Entities:
Keywords: Herba Cistanches; anti-oxidation; anti-senescence; neuroprotection
Year: 2017 PMID: 29344414 PMCID: PMC5758349 DOI: 10.14336/AD.2017.0720
Source DB: PubMed Journal: Aging Dis ISSN: 2152-5250 Impact factor: 6.745
The functions and mechanisms of Herba Cistanches extracts with anti-aging or anti-aging related effects.
| Extracts | Function | Mechanisms | Refs. |
|---|---|---|---|
| Ethanol extract of Herba Cistanches | Lifespan elongation | antagonize immunosenescence, exhibit analgesic and anti-inflammatory properties, improve blood circulation, increase the weights of the seminal vesicle, prostate gland and testes, modulate serum hormone level, induct testicular steroidogenic enzymes, delay accumulation of lactic acid, improve energy storage | [ |
| Cardioprotection | reduce oxidative stress, inhibit apoptotic pathways, | [ | |
| Neuroprotection | increase neuronal cell differentiation, neurite length, and synapse formation, upregulate NGF | [ | |
| Aqueous extract of Herba Cistanches | Lifespan elongation | inhibit cell apoptosis | [ |
| Antioxidant activity | inhibit activation of macrophage cells and nitric oxide production, scavenge free radicals | [ | |
| Hepatoprotection | inhibit lipid peroxidation in liver microsomes | [ | |
| Anti-neoplastic effect | upregulate nitric oxide synthase II expression, stimulate phagocytosis | [ | |
| Memory and learning enhancement | block Aβ 1-42 amyloid deposition | [ | |
| Anti-osteoporosis effect | regulate bone metabolism related genes e.g., Smad1, Smad5, TGF-β1 and TIEG1 | [ | |
| Aphrodisiac effect | alleviate spermatogenetic cell degeneration, modulate serum sex hormones levels | [ | |
| Methanol extract of Herba Cistanches | Cardioprotection | enhance mitochondrial glutathione status, decrease mitochondrial Ca2+ level, decrease myocardial ATP depletion, mitochondrial membrane potential and respiration rate | [ |
| Vasorelaxant activity | inhibit contractions induced by noradrenaline | [ | |
| Hepatoprotection | inhibit D-GalN-induced death of hepatocytes, reduce TNF-α-induced cytotoxicity in L929 cells | [ |
Phenylethanoid glycosides from Herba Cistanche.
| Active ingredient | R1 | R2 | R3 | R4 | R5 | R6 | R7 | Species | Refs. |
|---|---|---|---|---|---|---|---|---|---|
| 2'-Acetylacteoside (1) | Ac | Rha | Cf | H | OH | OH | H | Cd, Ct | [ |
| Acteoside (2) | H | Rha | Cf | H | OH | OH | H | Cd, Ct | [ |
| Cistanoside A (3) | H | Rha | Cf | Glc | Ome | OH | H | Cd, Ct | [ |
| Cistanoside B (4) | H | Rha | Fr | Glc | Ome | OH | H | Cd | [ |
| Cistanoside C (5) | H | Rha | Cf | H | Ome | OH | H | Cd | [ |
| Cistanoside D (6) | H | Rha | Fr | H | Ome | OH | H | Cd | [ |
| Cistanoside E (7) | H | Rha | H | H | Ome | OH | H | Cd | [ |
| Cistanoside G (8) | H | Rha | H | H | H | OH | H | Cd | [ |
| Cistanoside H (9) | Ac | Rha | H | H | OH | OH | H | Cd | [ |
| Decaffeoylacteoside (10) | H | Rha | H | H | OH | OH | H | Cd, Ct | [ |
| Echinacoside (11) | H | Rha | Cf | Glc | OH | OH | H | Cd, Ct | [ |
| Isoacteoside (12) | H | Rha | H | Cf | OH | OH | H | Cd, Ct | [ |
| Isosyringalide-3'-α-L-rhamnopyranoside (13) | H | Rha | Cm | H | OH | OH | H | Ct | [ |
| Osmanthuside (14) | H | Rha | Cm | H | H | OH | H | Cd | [ |
| Salidroside (15) | H | H | H | H | H | OH | H | Cd, Ct | [ |
| Syringalide A-3'-α-L-rhamnopyranoside (16) | H | Rha | Cf | H | H | OH | H | Cd, Ct | [ |
| Tubuloside A (17) | Ac | Rha | Cf | Glc | OH | OH | H | Cd, Ct | [ |
| Tubuloside B (18) | Ac | Rha | H | Cf | OH | OH | H | Cd, Ct | [ |
| Tubuloside C (19) | Ac | TA-Rha | Cf | Glc | OH | OH | H | Ct | [ |
| Tubuloside D (20) | Ac | TA-Rha | Cm | Glc | OH | OH | H | Ct | [ |
| Tubuloside E (21) | Ac | TA-Rha | Cm | H | OH | OH | H | Ct | [ |
| Cistantubuloside A (22) | H | Rha | Cf | Glc | H | OH | H | Ct | [ |
| Cistantubuloside B1/B2(23) | H | Rha | Cm/c-Cm | Glc | OH | OH | H | Ct | [ |
| Kankanoside F (24) | H | Rha | H | Glc | OH | OH | H | Ct | [ |
| Kankanoside G (25) | H | Rha | H | Cf | H | OH | H | Ct | [ |
| Cistantubuloside C1/C2 (26) | H | Rha | Cf | Glc | OH | OH | OH(S/R) | Ct | [ |
| Crenatoside (27) | Ct | [ | |||||||
| Cistanoside F (28) | Ct | [ |
Cf: trans-caffeoyl; Cm: trans-coumaroyl; c-Cm: cis-coumaroyl; Glc: β-glucopyranose. Rha: α-L-rhamnopyranose; TA-Rha: 2’’,3’’,4’’-triacetyl-α-L-rhamnopyranose; Ac: acetyl.
Cd: C. deserticola; Ct: C. tubulosa
Figure 1.The chemical structures of PhGs
(A) Chemical structure of compounds 1-26 in PhGs. (B) Chemical structure of compound 27 (Crenatoside) in PhGs. (C) Chemical structure of compound 28 (Cistanoside F) in PhGs.
The function and mechanisms of echinacoside with anti-aging and anti-aging related effects.
| Function | Mechanism | Refs. |
|---|---|---|
| Lifespan extension | induce cell cycle arrest and apoptosis via induction of oxidative DNA damage | [ |
| modulate nuclear localization and transcriptional activities of daf-16 | ||
| prevent decrease in membrane potential of fragmented mitochondria | ||
| increase expression of the anti-apoptotic protein Bcl-2 and inhibiting caspase-3 activity | ||
| stimulate intestinal epithelial cell proliferation and prevent cell death via up-regulation of TGF-β | ||
| Memory and learning enhancement | decrease P-tau phosphorylation and increase CRMP-2 expression level | [ |
| Antioxidant effect | improve anti-oxidant enzymes | [ |
| inhibit formation of NO | ||
| clear all free radicals, scavenge DPPH and OH free radicals | ||
| protect oxidative stress-induced organ injuries by entering cells through the injured membrane, affecting the signaling pathway between ROS and the opening of Ca2+ channel | ||
| Neuroprotection effect | reduce the levels of T-tau, TNF-α, and IL-1β | [ |
| inhibit cytochrome c release and caspase-3 activation via activating ERK pathway in neuronal cells | ||
| inhibit glutamate release by reducing voltage-dependent Ca2+ entry and suppressing protein kinase C activity | ||
| Anti-inflammation | block TNF-α-NO and COX-II-PGE2 pathways | [ |
| scavenge NO radical | ||
| upregulate TGF-β1 and increase the number of Ki67(+) proliferating cells in diseased colons | ||
| Anti-neurodegenerative effect | increase expression of GDNF and BDNF mRNA and protein, induce NTFs, inhibit apoptosis | [ |
| Immunomodulatory and anti-neoplastic effects | increase intracellular oxidized guanine, 8-oxoG, and upregulate double-strand DNA break (DSB)-binding protein 53BP | [ |
| increase caspase 3 and cleaved PARP, upregulate G1/S-CDK blocker CDKN1B (p21) via induction of oxidative DNA damage | ||
| Hepatoprotective effect | inhibit both ascorbic acid/Fe2+ and ADP/NADPH/Fe3+ induced lipid peroxidation | [ |
| reduce TNF-α-induced cytotoxicity | ||
| anti-hepatic fibrosis by reducing mRNA expression of NF-κB | ||
| inhibit hepatic stellate cell (HSC) activation, block conduction of TGF-β1/smad signaling pathways | ||
| decrease HBV replication and antigen expression | ||
| Anti-osteoporosis effect | stimulate osteoblastic bone formation by promoting bone regeneration in cultured osteoblastic MC3T3-E1 cells | [ |
| increase cell proliferation, ALP activity, COL I contents, OCN levels and mineralization in osteoblasts, elevate OPG/RANKL ratio and decrease receptor activator of nuclear factor-kB ligand (RANKL) level in serum | ||
| promote differentiation of bone marrow mesenchymal stem cells cultured | ||
| Aphrodisiac effect | increase sperm count and sperm motility and attenuate poor sperm quality and testicular toxicity in rats by up-regulating steroidogenesis enzymes including StAR, CYP11A1, 3β-HSD, 17β-HSD, CYP17A1 and CYP3A4 | [ |
| Anti-diabetic and anti-fatigue effects | suppress elevated fasting blood glucose and postprandial blood glucose levels, insulin resistance and dyslipidemia | [ |
| inhibit aldose reductase | ||
| enhance swimming capacity of mice by decreasing muscle damage, delay accumulation of lactic acid, and improve energy storage |
The functions and mechanisms of acteoside with anti-aging and anti-aging related effects.
| Function | Mechanism | Refs. |
|---|---|---|
| Lifespan extension | inhibit hepatic apoptosis | [ |
| Memory and learning enhancement | promote NGF and its neuronal actions, increase TrK A expression, upregulate NGF | [ |
| inhibit acetylcholine esterase and increase the activities of antioxidant enzymes | ||
| increase activity of GSH-Px, T-SOD, TChE and protein contents, and decrease MDA content | ||
| increase neurons and nissl bodies in the hippocampus, promote NGF and TrkA expression, decrease the content of nitric oxide, activity of nitric oxide synthase and expression of caspase-3 protein | ||
| Antioxidant effect | scavenge NO radical and DPPH radical | [ |
| decrease activity of nitric oxide synthase | ||
| inhibit both ascorbic acid/Fe2+ and ADP/NADPH/Fe3+ induced lipid peroxidation in rat liver microsomes | ||
| Neuroprotective effect | increase neurons and nissl bodies in the hippocampus | [ |
| inhibit rotenone-induced α-synuclein, caspase-3 upregulation and MAP-2 downregulation | ||
| block amyloid deposition, reverse cholinergic and hippocampal dopaminergic neuronal function | ||
| improve SK-N-SH cell morphology, enhance cell survival rate, decrease cell LDH release rate and expression of phosphorylated tau proteins at p-Ser 199/202 and p-Ser 404 sites, up-regulate the expression of non-phosphorylated tau proteins at Ser 202 site and Ser 404 sites | ||
| Anti-inflammatory effect | scavenge NO radical | [ |
| Immunomodulatory and anti-neoplastic effects | inhibit basophilic cell-derived immediate-type and delayed-type allergic reactions | [ |
| down-regulate expressions of the CCL1, CCL2, CCL3, CCL4, FCER1A and NFATC1 genes, inhibit MAPK pathway, and decrease JNK phosphorylation | ||
| Hepatoprotective effect | antioxidative, immunoregulatory, regulate hepatic apoptosis | [ |
| inhibit TNF-α-mediated hepatic apoptosis and subsequent necrosis in DGalN/LPS-induced liver failure | ||
| scavenge free radicals, inhibit lipid peroxidation, protect hepatic membranes | ||
| block the TGF-β1/smad signaling pathway and inhibit the activation of HSC | ||
| inhibit D-GalN-induced death of hepatocytes and reduce TNF-α-induced cytotoxicity in L929 cells | ||
| block P450-mediated bioactivation | ||
| Anti- hypercholesterolemia and anti-diabetic effects | enhance mRNA expressions of apolipoprotein B, VLDL receptor, and cytochrome P450 SCC in HepG2 hepatocytes, in diet-induced hypercholesterolemia mice | [ |
| improve glucose tolerance in starch-loaded mice |
The function and mechanisms of isoacteoside with anti-aging related effects.
| Function | Mechanism | Refs. |
|---|---|---|
| Antioxidant effect | scavenge free radical such as NO radical | [ |
| Hepatoprotective effect | inhibit both ascorbic acid/Fe2+ and ADP/NADPH/Fe3+ induced lipid peroxidation in rat liver microsomes | [ |
| reduce TNF-α-induced cytotoxicity | ||
| Neuroprotective effect | inhibit microglia-involved neuroinflammation | [ |
Active ingredients, functions and mechanisms of Polysaccharides from Herba Cistanches with anti-aging related effects.
| Function | Active ingredient | Mechanism | Refs. |
|---|---|---|---|
| Immunological activity | ACDP-2 | stimulate immune response | [ |
| Cistanche | stimulate the division of thymus lymphocyte, promote thymus intracellular calcium delivering | [ | |
| CDA-1A | stimulate B cell proliferation | [ | |
| CDA-3B | stimulate both T and B cell proliferation | [ | |
| Hepatoprotective effect | CDP-C | antioxidant, promote viability of HepG2 cells, | [ |
| Antioxidant activity | Cistanche tubulosa polysaccharide (CTP) | scavenge DPPH, OH and ABTS radical | [ |
| Anti-diabetic effect | Cistanche tubulosa polysaccharide (CTP) | suppress elevated fasting blood glucose and postprandial blood glucose levels, insulin resistance and dyslipidemia | [ |
Active ingredients, functions and mechanisms of Cistanche Salsa with anti-aging and anti-aging related effects.
| Active ingredient | Function | Mechanism | Refs. |
|---|---|---|---|
| Ethanol extract of Cistanche Salsa | Anti-osteoporosis effect | suppress bone weight loss | [ |
| Anti-proliferative | decrease prostate weight, serum dihydrotestosterone concentration, and mRNA expression of 5α-reductase type 1 and type 2, regulate the expression levels of inflammatory-related proteins and apoptosis-associated proteins | [ | |
| Phenylethanoid | Neuroprotective effect | prevent cell apoptosis, protect dopaminergic neurons against dopamine neurotoxicity induced by MPTP | [ |
| Echinacoside | Lifespan extension | protect cells from DNA damage, trigger cells in the G1 phase to enter the S phase and G2 phase, improve ROS degradation | [ |
| protect neuronal cells from apoptosis | |||
| maintain mitochondrial function, decrease the generation of ROS, increase the expression of the antiapoptotic protein Bcl-2 and inhibit caspase-3 activity | |||
| Anti-inflammatory | reduce inflammatory markers, including myeloperoxidase, extracellular nucleosomes, high-mobility group box 1, and inflammatory cytokines | [ | |
| Neuroprotective effect | inhibit caspase-3 and caspase-8 activation in cerebellar granule neurons | [ | |
| reduce ROS production, attenuate neurotoxicity mitochondrial dysfunction and inflammatory responses induced by 6-OHDA | |||
| suppress expression of apoptotic genes | |||
| inhibit generation of MPP+-induced ROS | |||
| decrease striatal extracellular levels of DA, DOPAC and HVA | |||
| Anti-neurodegenerative effect | attenuate neurotoxicity mitochondrial dysfunction and inflammatory responses | [ | |
| suppress dopaminergic neuron loss caused by MPP+ or MPTP | |||
| maintain dopamine content and dopamine metabolite content | |||
| increase striatal dopamine and dopamine metabolite levels | |||
| inhibit apoptosis and activation of microglia and astrocytes in the substantia nigra | |||
| regulate cytokines such as p38 MAPK and NF-κB p52 subunit | |||
| Anti-oxidant effect | decrease generation of ROS and protect oxidative-stress-induced toxic injuries | [ | |
| Anti-neoplastic effect | inhibit prostate cancer cell proliferation | [ | |
| modulate MAPK activity | |||
| Acteoside | Skin-protective effect | enhance scavenging activity of ROS, decrease Bax/Bcl-2 ratio and downregulate activity of pro caspase-3 | [ |
| modulate the MAPK signaling pathway | |||
| Neuroprotective effect | inhibit neuronal death induced by MPP+ and glutamate | [ | |
| Tubuloside B | Neuroprotective effect | inhibit cell apoptosis, attenuate MPP+ induced cytotoxicity, DNA fragmentation, and intracellular accumulation of ROS, anti-oxidative stress effects, maintenance of mitochondria function, decrease of concentration of free intracellular calcium, inhibition of caspase-3 activity | [ |
| (2E,6R)-8-Hydroxy-2,6-dimethyl-2-octenoic acid [(R)-HDOA] | Anti-osteoporosis effect | decrease bone weight and mechanical strength | [ |